Complement Therapeutics
Developer of a biotechnology platform designed to treat chronic diseases driven by the dysregulation of the complement system. The company's platform aims to design a methodology that stratifies patie...
Valuation
$0
Share Price
N/A
Total Raised
$84.1M
Last Round
N/A